Clinical trial
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
NCT00004080 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004080 |
|---|---|
| Title | Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors |
| Official title | Assessment of the Safety and Transduction Efficiency of SCH58500, An Adenoviral Vector p53 Delivery System, to Patients With Recurrent Malignant Brain Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Procedure |
| Interventions | recombinant adenovirus-p53 SCH-58500, conventional surgery |
| Start date | Dec 1, 1999 |
| First posted | Aug 5, 2004 |
| Last update posted | Feb 9, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: